Complications for procedure to open clogged pulmonary arteries decrease significantly

For chronic thromboembolic pulmonary hypertension, or CTEPH, balloon pulmonary angioplasty is a novel, nonsurgical treatment

10:11 AM

Author | Noah Fromson

doctors in surgery case looking at screen blue scrubs
The review of a pulmonary angiogram during a balloon pulmonary angioplasty procedure. Credit: Chris Hedley

For patients with high blood pressure in their pulmonary arteries caused by chronic blood clots, complications after a minimally invasive balloon angioplasty have decreased substantially over the last decade, a Michigan Medicine-led study finds. 

Researchers examined over 7,500 cases of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension, an elevated blood pressure in the pulmonary arteries due to persistent blockages known as CTEPH, between 2013 and 2022. The procedure, which is offered for patients who are not candidates for surgery, involves inflating a balloon inside of diseased lung arteries to break up clots and restore blood flow to the lungs.

Results published in JACC: Cardiovascular Interventions reveal that the once feared severe complications that occur during balloon pulmonary angioplasty — lung injury, coughing up blood and death — all dropped in the latter half of the study decade.

From 2013 to 2017, 11.3% of CTEPH patients experienced lung injury after balloon pulmonary angioplasty, compared to 1.4% between 2018 and 2022. During those same time periods, instances of patients coughing up blood dropped from 14.1% to 7.7% and mortality decreased from 2% to 0.8%.

“Over the last decade, it is clear that balloon pulmonary angioplasty has become a more established, safer option for inoperable CTEPH,” said senior author Vikas Aggarwal, MBBS, interventional cardiologist at the University of Michigan Health Frankel Cardiovascular Center. “We believe these decreased complication rates are largely due to refinement in technique, as well as patient selection. We are learning how to do this procedure in a safer manner with increasing experience over time.”

SEE ALSO: A worsening lung disease deemed hopeless, until doctors tried this treatment

The minimally invasive procedure is performed at select centers worldwide, most often done in an inpatient setting with patients monitored for one to three days after. Another Michigan Medicine-led study in 2023 found that balloon pulmonary angioplasty can be safely performed in an outpatient setting utilizing a novel care delivery protocol.

Outside of balloon pulmonary angioplasty, there are few nonsurgical treatments for CTEPH, which can develop in nearly 5% of all patients with acute pulmonary embolism. Some patients will be treated with lifelong anticoagulation and riociguat, the only approved medication to dilate blood vessels in patients with CTEPH.

“As it becomes clearer that balloon pulmonary angioplasty is a safe and effective treatment that can be carried out in both the inpatient and outpatient setting, there is potential for more centers across the country to start CTEPH programs,” said Victor Moles, M.D., co-author and clinical assistant professor of internal medicine-cardiology at U-M Medical School.

Michigan Medicine is contributing to expanding the knowledge and experience of the procedure by offering complimentary, live on-site programs where interested institutions can learn how to successfully implement balloon pulmonary angioplasty.

“These programs have the potential to greatly increase access and quality of care in treatment of CTEPH,” said Aggarwal, who is also a clinical assistant professor of internal medicine-cardiology at U-M Medical School.

Additional authors include Nishant Jain, M.D., Victor Moles, M.D., Prachi P. Agarwal, M.D., Jonathan Haft M.D., Thomas Cascino, M.D., Kenneth Rosenfield, M.D. Brahmajee K. Nallamothu, M.D., Vallerie McLaughlin, M.D. Whitney Townsend , all of University of Michigan, Muhammad Sheikh, M.D., Southern Illinois University School of Medicine, Divyansh Bajaj, M.D.,  Medical College of Wisconsin, Richard Krasuski, M.D., Duke University Medical Center, Eric Secemsky, M.D., Beth Israel Deaconess Medical Center, Saurav Chatterjee, M.D., North Shore-Long Island Jewish Medical Centers and Scott Visovatti, M.D., Ohio State University. 

Papers cited:

Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies,” JACC: Cardiovascular Interventions. DOI: 0.1016/j.jcin.2023.01.361

Safe and Effective Balloon Pulmonary Angioplasty in the Outpatient Setting: The Michigan Medicine Experience,” Journal of the Society for Cardiovascular Angiography & Interventions. DOI: 10.1016/j.jscai.2023.100589


More Articles About: Lungs and Breathing Hypertension and High Blood Pressure Vascular Disease Cardiovascular: Treatment & Surgery Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories patient family and child life team member smiling and then a photo next to that one with the same worker helping someone in a wheelchair in a patient office
Health Lab
A pediatric program helping adults through cardiovascular disease, surgery
A child life program that has helped kids and their families reduce stress and anxiety associated with hospitalization and illness is now finding success with adult patients undergoing complex heart procedures as well.
older man with glasses standing at balcony with back to glass windows
Health Lab
Roy’s Michigan Answer: Second opinion saves patient’s heart
Michigan Medicine's team of cardiology experts offered an advanced, minimally invasive coronary intervention, which restored one patient back to good health
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Greenspace and Late-Life Cognitive Decline
In this episode Matt and Lauren will speak with Dr. Marcia Pescador Jimenez, an Assistant Professor in the Department of Epidemiology at Boston University whose research focuses on understanding the relationship between exposure to green space and health outcomes (including hypertension and cognitive measures). Emerging research has shown that midlife risk factors may delay or even prevent the onset of dementia later in life - among these include physical activity and social interaction. It’s not a stretch to imagine how a person’s environment may impact behaviors such as physical activity. For instance, there are places that lack sidewalks and parks that make exercising exceedingly difficult. Among environmental epidemiologists, there is growing interest in understanding how the built and natural environment influence our behaviors that, in turn, influence our health. We encourage you to listen to this episode while on a walk outside!
see through blue person with red lines running through neck to chest
Health Lab
What is phrenic neuropathy?
Phrenic neuropathy is a condition that impacts the nerve around the diaphragm making it harder to breathe, especially in situations such as lying down or being in water. The condition is treatable, with surgical intervention, physical therapy or by letting it heal over time.
baby laying down with stethoscope over chest doctors hands
Health Lab
Comparing life threatening illness risk between two surgeries for infants with congenital heart disease
Newly presented data suggest that infants who receive a hybrid stage I palliation – a less invasive alternative for initial treatment – more commonly develop necrotizing enterocolitis compared to those who receive the standard Norwood operation, a complex open heart surgery.
purple gloves close up holding piece
Health Lab
Recycled pacemakers function as well as new devices, international study suggests
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.